Displaying drugs 2676 - 2700 of 2779 in total
Name | Weight | Structure | Description | Categories |
---|---|---|---|---|
Uridine triacetate | 370.314 C15H18N2O9 | A pyrimidine analog used for the reversal of overdose, regardless of the presence of symptoms, and early-onset, severe or life-threatening CNS toxicity or cardiotoxicity of fluorouracil or capecitabine. | Various Alimentary Tract and Metabolism Products | |
Ursodeoxycholic acid | 392.572 C24H40O4 | A bile acid used for the treatment of primary biliary cirrhosis (PBC). | Bile Acid Preparations / Bile acids and derivatives | |
Vaborbactam | 297.13 C12H16BNO5S | A beta lactamase inhibitor used to treat complicated urinary tract infections. | beta-Lactamase Inhibitors | |
Vadadustat | 306.7 C14H11ClN2O4 | An oral hypoxia-inducible factor prolyl-hydroxylase inhibitor used to treat symptomatic anemia associated with chronic kidney disease in adults on chronic maintenance dialysis. | Amino Acids / Amino Acids, Peptides, and Proteins / Antianemic Preparations / BCRP/ABCG2 Inhibitors / Blood and Blood Forming Organs / Cytochrome P-450 CYP2B6 Inducers / Cytochrome P-450 CYP2B6 Inducers (weak) / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C9 Inhibitors / Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Enzyme Inhibitors / Erythropoiesis-Stimulating Agents / Hypoxia-Inducible Factor-Proline Dioxygenases, antagonists & inhibitors / OAT3/SLC22A8 Inhibitors / OAT3/SLC22A8 Substrates / Pyridines / UGT1A1 Inducers / UGT1A1 Substrates / UGT1A9 Substrates / UGT2B7 substrates | |
Valaciclovir | 324.3357 C13H20N6O4 | An guanine nucleoside antiviral used to treat herpes exacerbations. | Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors | |
Valbenazine | 418.578 C24H38N2O4 | A vesicular monoamine transporter 2 inhibitor used to treat tardive dyskinesia and chorea associated with Huntington's disease. | Vesicular Monoamine Transporter 2 Inhibitor | |
Valdecoxib | 314.359 C16H14N2O3S | A COX-2 inhibitor used to treat osteoarthritis and dysmenorrhoea. | COX-2 Inhibitors / Selective Cyclooxygenase 2 Inhibitors (NSAIDs) | |
Valganciclovir | 354.3617 C14H22N6O5 | An antiviral medication used to treat cytomegalovirus (CMV) retinitis in patients diagnosed with acquired immunodeficiency syndrome (AIDS). | Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors | |
Valine | 117.1463 C5H11NO2 | An amino acid commonly found as a component of total parenteral nutrition. | Amino Acids, Branched-Chain / Amino Acids, Essential | |
Valproate bismuth | 638.598 C24H45BiO6 | A medication used to treat laryngitis. | Neurotoxic agents | |
Valproic acid | 144.2114 C8H16O2 | An anticonvulsant used to control complex partial seizures and both simple and complex absence seizures. | Fatty Acid Derivatives | |
Valrubicin | 723.651 C34H36F3NO13 | An anthracycline used intravesically in the treatment of BCG-resistant bladder carcinoma. | Anthracyclines and Related Substances | |
Valsartan | 435.5188 C24H29N5O3 | An angiotensin-receptor blocker used to manage hypertension alone or in combination with other antihypertensive agents and to manage heart failure in patients who are intolerant to ACE inhibitors. | Angiotensin II Antagonists and Calcium Channel Blockers / Angiotensin II Antagonists and Diuretics / Angiotensin II receptor blockers (ARBs) and calcium channel blockers / Angiotensin II receptor blockers (ARBs) and diuretics | |
Vamorolone | 356.462 C22H28O4 | A synthetic glucocorticoid used as an anti-inflammatory and immunosuppressant in the management of Duchenne muscular dystrophy (DMD). | Anti-Inflammatory Agents | |
Vanadium | 50.9415 V | A micronutrient used in some multivitamins and parenteral nutrition. | Metals, Heavy / Trace Elements / Transition Elements | |
Vancomycin | 1449.254 C66H75Cl2N9O24 | A glycopeptide antibiotic used to treat severe but susceptible bacterial infections such as MRSA (methicillin-resistant Staphylococcus aureus) infections. | Anti-Bacterial Agents | |
Vandetanib | 475.354 C22H24BrFN4O2 | An antineoplastic kinase inhibitor used to treat symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease. | Protein Kinase Inhibitors | |
Vanillyl butyl ether | 210.2695 C12H18O3 | Vanillyl butyl ether is an ether of monohydroxybenzoic acid. It is added to food products as a flavoring agent. It is also present in cosmetics and personal care products as... | Not Annotated | |
Vardenafil | 488.603 C23H32N6O4S | A phosphodiesterase 5 inhibitor used to treat erectile dysfunction. | Drugs Used in Erectile Dysfunction | |
Varenicline | 211.268 C13H13N3 | A partial agonist at nicotinic acetylcholine receptors used as an aid in smoking cessation. | Drugs Used in Nicotine Dependence | |
Vasopressin | 2140.46 C92H130N28O24S4 | A peptide hormone used to increase blood pressure in patients with vasodilatory shock who are resistant to fluid and catecholamine therapy. | Vasopressin and Analogues | |
Vecuronium | 557.8274 C34H57N2O4 | A nondepolarizing neuromuscular blocking agent used to relax muscles or as an adjunct in general anesthesia during surgical procedures. | Androstanols / Neuromuscular-Blocking Agents (Nondepolarizing) / Nicotinic Antagonists | |
Velpatasvir | 883.019 C49H54N8O8 | A NS5A inhibitor used to treat chronic hepatitis C infections in patients without cirrhosis or with compensated cirrhosis. | Antivirals for treatment of HCV infections | |
Vemurafenib | 489.922 C23H18ClF2N3O3S | A kinase inhibitor used to treat patients with Erdheim-Chester Disease who have the BRAF V600 mutation, and melanoma in patients who have the BRAF V600E mutation. | B-Raf serine-threonine kinase (BRAF) inhibitors / Protein Kinase Inhibitors / Sulfonamides | |
Venetoclax | 868.45 C45H50ClN7O7S | A BCL-2 inhibitor used to treat chronic lymphocytic leukemia, small lymphocytic lymphoma, or acute myeloid leukemia. | BCL-2 Inhibitor |
Displaying drugs 2676 - 2700 of 2779 in total